Condition (MeSH)
Epidermolysis Bullosa Acquisita
ClinicalTrials.gov lists 4 trials for Epidermolysis Bullosa Acquisita or a narrower condition beneath it. National Center for Research Resources (NCRR) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Epidermolysis Bullosa Acquisita itself; the rest are tagged with a narrower condition beneath it.
When did Epidermolysis Bullosa Acquisita trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 1996 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Epidermolysis Bullosa Acquisita trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 1 |
| Phase 4 | 1 |
How many Epidermolysis Bullosa Acquisita trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Epidermolysis Bullosa Acquisita trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 1 |
Which publications cover Epidermolysis Bullosa Acquisita? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering. | Nature communications | 2013 | Yes |
| Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management. | Drugs & aging | 2010 | Yes |
| Autoimmune bullous skin diseases. Part 1: Clinical manifestations. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2011 | No |
| Double filtration plasmapheresis can decrease factor XIII Activity. | Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2007 | No |
Prevalence (21)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Epidermolysis bullosa acquisita | Annual incidence | <1 / 1 000 000 | Germany | Not stated | Unspecified |
| Epidermolysis bullosa acquisita | Annual incidence | <1 / 1 000 000 | Europe | Not stated | Unspecified |
| Epidermolysis bullosa acquisita | Annual incidence | <1 / 1 000 000 | Serbia | Not stated | Exact |
| Epidermolysis bullosa acquisita | Annual incidence | <1 / 1 000 000 | Germany | Not stated | Exact |
| Epidermolysis bullosa acquisita | Annual incidence | <1 / 1 000 000 | Europe | Not stated | Exact |
Showing 5 of 21 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Epidermolysis bullosa acquisita | 46487 | Exact | Orphadata Science knowledge files, Product 1 |
| Epidermolysis bullosa acquisita | 46487 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.